# Chromium Carnosinate

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/chromium-carnosinate
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-04
**Evidence Score:** 2 / 10
**Category:** Mineral
**Also Known As:** Chromium carnosine complex, Cr-carnosinate, Chromium-carnosine chelate

## Overview

Chromium carnosinate is a theoretical or proprietary chromium chelate purportedly combining trivalent chromium (Cr³⁺) with the dipeptide carnosine (beta-alanyl-L-histidine). No peer-reviewed studies, pharmacological data, or clinical trials documenting its existence, synthesis, or biological activity have been identified in the scientific literature.

## Health Benefits

• No health benefits documented - compound not found in scientific literature
• No clinical evidence exists for any biomedical applications
• No studies available on physiological effects or therapeutic uses
• No research on metabolic, [cardiovascular](/ingredients/condition/heart-health), or other health impacts
• No evidence base for supplementation purposes

## Mechanism of Action

No documented mechanism of action exists for chromium carnosinate in the peer-reviewed literature. Theoretically, if the compound were synthesized, trivalent chromium (Cr³⁺) might interact with insulin receptor signaling pathways via chromodulin (low-molecular-weight chromium-binding substance), while the carnosine moiety could contribute [antioxidant activity](/ingredients/condition/antioxidant) through histidine imidazole ring proton buffering. However, these are speculative extrapolations from separate compounds and have not been demonstrated for chromium carnosinate specifically.

## Clinical Summary

No clinical trials, animal studies, or in vitro experiments investigating chromium carnosinate have been identified in PubMed, ClinicalTrials.gov, or any indexed biomedical database as of the current knowledge date. The compound does not appear in established pharmacopoeias, regulatory approval databases (FDA, EMA), or recognized supplement ingredient registries. Without any published data, no conclusions about efficacy, optimal dosage, or therapeutic application can be drawn. The absence of evidence should be clearly distinguished from evidence of absence, but caution is strongly warranted given the complete lack of a scientific foundation.

## Nutritional Profile

Chromium Carnosinate is not a recognized or well-characterized mineral compound in the scientific or nutritional literature. It would theoretically represent a chelate of chromium (Cr³⁺) with L-carnosine (β-alanyl-L-histidine), combining a trace mineral with a dipeptide ligand. However, no verified data on its synthesis, stability, or nutritional composition exists. Hypothetical profile based on its putative constituents: • Chromium (Cr³⁺): If formulated similarly to other chromium chelates (e.g., chromium picolinate, chromium histidinate), elemental chromium content would likely range from ~8–15% by molecular weight depending on stoichiometry (estimated ~52 g/mol Cr per ~278 g/mol carnosine ligand, yielding roughly 10–16% Cr in a 1:1 or 1:2 complex). • L-Carnosine moiety: ~84–90% of molecular weight; provides β-alanine and L-histidine residues, which individually are bioactive ([antioxidant](/ingredients/condition/antioxidant), pH-buffering, metal-chelating properties). • No vitamins, fiber, fat, or caloric content as a pure mineral-amino acid chelate. • No macronutrient contribution at supplemental doses. • Bioavailability: Unknown. By analogy with chromium histidinate (CrHis, which uses histidine — a component of carnosine), organic chromium chelates generally show higher bioavailability than inorganic forms (e.g., chromium chloride). Carnosine's imidazole ring (from histidine) and amino groups could theoretically coordinate Cr³⁺ effectively, but no absorption, distribution, [metabolism](/ingredients/condition/weight-management), or excretion (ADME) data exist for this specific compound. • No standardized concentration, purity, or formulation data available. • No established Adequate Intake (AI) or dosing based on this compound; general chromium AI is 25–35 µg/day for adults (IOM). • Compound is not listed in USDA, EFSA, or any pharmacopeial databases. All values above are theoretical extrapolations; no empirical nutritional analysis has been published.

## Dosage & Preparation

No clinically studied dosages exist for Chromium Carnosinate as no research has been conducted on this compound. No forms, extracts, or standardization protocols are documented. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

No safety data, toxicology studies, or adverse event reports for chromium carnosinate exist in the scientific literature. Because the compound's chemical identity and bioavailability are uncharacterized, risks from chromium accumulation, potential [oxidative stress](/ingredients/condition/antioxidant) from hexavalent chromium (Cr⁶⁺) contamination, or carnosine-mediated drug interactions cannot be ruled out. Individuals taking insulin or oral hypoglycemic agents (e.g., metformin) should exercise particular caution with any unverified chromium compound due to additive hypoglycemic risk. Use during pregnancy or lactation is not advisable given the total absence of safety evaluation.

## Scientific Research

No clinical trials, RCTs, meta-analyses, or PubMed citations exist for Chromium Carnosinate. The research dossier indicates this compound is not recognized in scientific literature, with results instead describing only chemical properties of chromium carbonate variants.

## Historical & Cultural Context

No historical or traditional medicinal uses are documented for Chromium Carnosinate in any medical system. The compound appears to be either non-existent or a misnomer with no established cultural or traditional applications.

## Synergistic Combinations

None established - compound not recognized in scientific literature

## Frequently Asked Questions

### Is chromium carnosinate found in any scientific studies?

No peer-reviewed studies on chromium carnosinate appear in major biomedical databases including PubMed or Scopus. The compound has not been identified in indexed pharmacological, biochemical, or clinical research as a characterized substance with documented properties.

### How does chromium carnosinate differ from chromium picolinate?

Chromium picolinate is a well-studied Cr³⁺ chelate with picolinic acid, supported by multiple human clinical trials demonstrating modest effects on insulin sensitivity and HbA1c in type 2 diabetics at doses of 200–1000 mcg/day. Chromium carnosinate, by contrast, has no published synthesis protocol, no characterized bioavailability data, and no clinical trials, making any direct comparison scientifically impossible.

### What is carnosine and why might it be combined with chromium?

Carnosine (beta-alanyl-L-histidine) is a naturally occurring dipeptide found in skeletal muscle and brain tissue, studied for its antioxidant, anti-glycation, and pH-buffering properties via the imidazole ring of its histidine residue. A theoretical rationale for combining it with chromium might involve synergistic anti-glycation or insulin-sensitizing effects, but no experimental evidence supports this hypothesis for chromium carnosinate specifically.

### Is chromium carnosinate safe to take as a supplement?

Safety cannot be established for chromium carnosinate because no toxicology studies, pharmacokinetic data, or human safety trials have been conducted or published. Without knowing the compound's absorption rate, metabolic fate, or potential for Cr³⁺ accumulation in tissues, supplementation carries unquantifiable risk and cannot be recommended by evidence-based standards.

### What chromium supplements actually have clinical evidence?

Chromium picolinate and chromium nicotinate (niacin-bound chromium) have the strongest clinical evidence bases, with randomized controlled trials enrolling 40–200+ participants showing improvements in fasting glucose, insulin sensitivity, and lipid profiles at doses of 200–1000 mcg/day. Chromium histidinate has also shown positive results in animal models and limited human trials, particularly regarding oxidative stress markers and glucose metabolism.

### What should I know before buying a chromium carnosinate supplement?

Chromium carnosinate is a relatively obscure supplement ingredient with no published scientific research documenting its effects or benefits in humans. Before purchasing, be aware that manufacturers may make claims that lack clinical evidence, and you should verify whether the product's promises are supported by peer-reviewed studies. It's advisable to consult with a healthcare provider to determine if evidence-based chromium forms or other supplements might be more appropriate for your health goals.

### Does chromium carnosinate have any documented side effects or toxicity concerns?

Because chromium carnosinate has not been studied in clinical research, its safety profile, side effects, and potential toxicity thresholds remain unknown. The absence of scientific data means adverse effects cannot be reliably characterized, making it impossible to establish safe dosage ranges. Anyone considering this ingredient should exercise caution and discuss it with a healthcare provider, as unpublished compounds carry inherent uncertainty about tolerability.

### Why is chromium carnosinate rarely recommended by healthcare professionals?

Chromium carnosinate lacks clinical evidence of efficacy and has not been validated in peer-reviewed scientific literature, making it difficult for healthcare providers to recommend with confidence. Established chromium forms—such as chromium picolinate or chromium polynicotinate—have at least some research examining their metabolic effects, whereas chromium carnosinate has none. Without research demonstrating physiological benefits or optimal use cases, most evidence-based practitioners default to alternatives with documented safety and efficacy data.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*